Nu-Med Plus

About:

Nu-Med Plus is a medical device company that develops a patented technology to safely deliver precision doses of nitric oxide.

Website: http://nu-medplus.com

Twitter/X: numedplus

Description:

Nu-Med Plus develops a patented technology to safely deliver precision doses of nitric oxide. A line of innovative systems is being developed to serve new patient populations. Delivered correctly, nitric oxide holds the potential to dilate constricted blood vessels in heart patients and heal respiratory complications in newborns. The company scientists employ patented and patent-pending technology to also explore the potential of nitric oxide to treat wound care and those suffering from malaria, COPD, tuberculosis, and ARDS. The company was established in 2011 and is based in Salt Lake City, Utah, United States.

Total Funding Amount:

$992000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2011-01-01

Contact Email:

jeff(AT)nu-medplus.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-09-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai